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Brain networks modulated by subthalamic
nucleus deep brain stimulation
Ettore A. Accolla,1,2 Maria Herrojo Ruiz,1,3 Andreas Horn,1 Gerd-Helge Schneider,4
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Deep brain stimulation of the subthalamic nucleus is an established treatment for the motor symptoms of Parkinson’s disease.
Given the frequent occurrence of stimulation-induced affective and cognitive adverse effects, a better understanding about the role
of the subthalamic nucleus in non-motor functions is needed. The main goal of this study is to characterize anatomical circuits
modulated by subthalamic deep brain stimulation, and infer about the inner organization of the nucleus in terms of motor and
non-motor areas. Given its small size and anatomical intersubject variability, functional organization of the subthalamic nucleus is
difﬁcult to investigate in vivo with current methods. Here, we used local ﬁeld potential recordings obtained from 10 patients with
Parkinson’s disease to identify a subthalamic area with an analogous electrophysiological signature, namely a predominant beta
oscillatory activity. The spatial accuracy was improved by identifying a single contact per macroelectrode for its vicinity to the
electrophysiological source of the beta oscillation. We then conducted whole brain probabilistic tractography seeding from the
previously identiﬁed contacts, and further described connectivity modiﬁcations along the macroelectrode’s main axis. The desig-
nated subthalamic ‘beta’ area projected predominantly to motor and premotor cortical regions additional to connections to limbic
and associative areas. More ventral subthalamic areas showed predominant connectivity to medial temporal regions including
amygdala and hippocampus. We interpret our ﬁndings as evidence for the convergence of different functional circuits within
subthalamic nucleus’ portions deemed to be appropriate as deep brain stimulation target to treat motor symptoms in Parkinson’s
disease. Potential clinical implications of our study are illustrated by an index case where deep brain stimulation of estimated
predominant non-motor subthalamic nucleus induced hypomanic behaviour.
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Introduction
Deep brain stimulation (DBS) of the subthalamic nucleus
(STN) in Parkinson’s disease leads to effective reduction of
motor symptoms and improvement of quality of life (Krack
et al., 2003; Schuepbach et al., 2013). Despite its efﬁcacy in
ameliorating motor symptoms, DBS of the STN is also
associated with affective, behavioural and cognitive adverse
effects (Voon et al., 2006; Castrioto et al., 2014; Welter
et al., 2014). The most frequently observed symptoms in-
clude emotional instability (Krack et al., 2001; Odekerken
et al., 2013) additional to induction of (hypo)manic epi-
sodes (Kulisevsky et al., 2002; Mallet et al., 2007; Ulla
et al., 2011; Chopra et al., 2012; Welter et al., 2014)
and impulsivity changes (Frank et al., 2007; Cavanagh
et al., 2011), alongside depression and apathy most prob-
ably due to medication reduction (Okun et al., 2009;
Thobois et al., 2010; Witt et al., 2012). Given that one
of the main determinants of clinical outcome is the precise
location of the macroelectrode (Castrioto et al., 2014), a
detailed knowledge of STN anatomy is particularly relevant
for optimal target choice and DBS efﬁciency.
Although recently disputed (Alkemade and Forstmann,
2014; Lambert et al., 2015), mounting evidence from ana-
tomical, neurophysiological and clinical studies conﬁrms
the notion of a tripartite functional organization of the
human STN (Krack et al., 2001; Hamani et al., 2004;
Mallet et al., 2007; Karachi et al., 2009; York et al.,
2009). Despite the assumption of functional specialization,
the putative segregated sensorimotor, associative and limbic
territories show substantial areas of overlap (Haynes and
Haber, 2013). The STN functional subregions can be dis-
tinguished with a certain degree of precision using neuro-
physiological markers, a procedure that is widely used in
the clinical routine for electrode implantation (Rodriguez-
Oroz et al., 2001; Abosch et al., 2002; Marceglia et al.,
2010; Kinfe and Vesper, 2013). In patients with
Parkinson’s disease, local ﬁeld potential (LFP) recordings
from the STN demonstrated enhanced oscillations in the
beta band (13–30Hz), which is substantially and consist-
ently reduced after the intake of levodopa along with symp-
tom improvement (Ku¨hn et al., 2006; Hammond et al.,
2007). Interestingly, neurons with predominant ﬁring at
frequencies within the beta range or those that are locked
to oscillatory beta band activity are signiﬁcantly more
abundant in the dorso-lateral portion of the STN
(Weinberger et al., 2006; Trottenberg et al., 2007; Zaidel
et al., 2010), a region that is part of the cortico-basal gang-
lia motor loop (Haynes and Haber, 2013). Beta activity
could therefore be considered as the electrophysiological
signature of the sensori-motor function within the
dorso-lateral STN (Chen et al., 2006; Trottenberg et al.,
2007; Zaidel et al., 2010).
An inherent limitation when studying in vivo the anatom-
ical and functional organization of the STN is due to the
high level of interindividual variability (Richter et al.,
2004). Addressing this limitation, we combine neurophysio-
logical recordings with brain imaging data from
Parkinson’s disease patients undergoing DBS of the STN.
The main goal of the study was to obtain ﬁne-grained topo-
graphical information about the STN functional subregions
through characterization of its anatomical and functional
connectivity patterns. To this aim, we used LFP recordings
from DBS macroelectrodes within the STN in parallel with
investigation of the anatomical connectivity of the very
same DBS contacts based on probabilistic diffusion tracto-
graphy. Finally, we analysed how connectivity values vary
along the macroelectrode main axis. Based on the clinical
observation of reduction of DBS-induced psychiatric symp-
toms when shifting the stimulation site dorsally (Welter
et al., 2014), we hypothesized that different patterns of
connectivity to limbic cortical structures differentiate neigh-
bouring contacts in the electrodes implanted in the STN of
patients with Parkinson’s disease.
Materials and methods
We acquired data from 10 idiopathic Parkinson’s disease pa-
tients recruited at the Charite´ Movement Disorders clinic and
scheduled for DBS based on clinical decision. Inclusion criteria
were an established clinical diagnosis of idiopathic Parkinson’s
disease, a proven response to levodopa and the absence of
other neurological or psychiatric diagnosis not related to
Parkinson’s disease. STN targeting and stereotactic surgery
were performed according to a standard protocol as detailed
previously (Ku¨hn et al., 2009).
All subjects gave informed written consent to the study,
which was approved by the local Ethics committee.
Demographic and available clinical information is summarized
in Table 1. Levodopa equivalent daily dosage was calculated
according to a recent systematic review (Tomlinson et al.,
2010).
Pre-surgery MRI
Before surgery, all patients underwent quantitative multi-param-
eter brain imaging and diffusion-weighted imaging on a 3 T
whole-body MRI system (Magnetom TIM Trio, Siemens
Healthcare) using a 32-channel radio frequency head receive
coil and radio frequency body transmit coil. The quantitative
MRI protocol consisted of 3D multi-echo FLASH datasets with
predominantly proton density weighting (repetition
time = 23.7ms, ﬂip angle  = 6), T1-weighting (repetition








(repetition time/ = 23.7ms/6) contrast according to the previ-
ously published protocol (Draganski et al., 2011; Weiskopf
et al., 2013).
The diffusion-weighted imaging protocol was performed with
the following parameters: echo time = 80ms, repetition time
8300ms, acquisition matrix 128  128 voxels, 74 axial slices,
yielding voxel size of 1.7  1.7  1.7mm, bandwidth = 2003Hz/
pixel, diffusion weighting at a high b = 1000 s/mm2 along 60
directions and six reference volumes at zero b-value acquired
one every 10th high b-value acquisition.
Post-surgery local ﬁeld
potential recordings
Patients were studied 2–6 days after DBS implantation with
externalized DBS electrodes and prior to their connection to
the stimulator device (Macroelectrode 3389, Medtronic).
Bipolar LFP activity was recorded from adjacent contact
pairs (01, 12, 23) in each DBS electrode, where 0 is the
most ventral and 3 is the most dorsal contact (R = right,
L = left). Signals were ampliﬁed 50 000-fold and ﬁltered at
0.5–250Hz on a Digitimer D360 (Digitimer Ltd) and recorded
through a 1401 A-D converter (Cambridge Electronic Design)
onto a computer using Spike2 software (Cambridge Electronic
Design). Signals were sampled at 1 kHz (except in Patient 4,
where signals were sampled at 826Hz) and monitored on-line.
In all patients, LFP recordings of 3–5min duration were
performed at rest (i) after overnight withdrawal of dopamin-
ergic mediation (OFF); and (ii) 1 h after intake of 200mg of
levodopa or 1.5 times the patient-speciﬁc morning levodopa
dose (ON). For the analysis of the LFP signals a segment of
180 s without muscle or ocular artefacts was selected for each
patient from the OFF and ON LFP recordings.
Post-surgery MRI
Within 5 days after surgery, patients underwent brain MRI as
part of the clinical protocol to conﬁrm the planned localization
of the electrodes. Dedicated T2-weighted fast-spin echo
sequences were acquired in a 1.5 T MRI machine (NT
Intera; Philips Medical Systems), with the following
parameters: repetition time/echo time, 3500/138ms; echo-
train length, 8; excitations, 3; ﬂip angle, 90; section thickness,
2mm; ﬁeld of view, 260mm (in-plane resolution
0.51  0.51mm); matrix size, 384 interpolated to 512; total
acquisition time, 10min 41 s; Philips software Version 11.1
level 4. This protocol allowed us to respect the manufacturer
speciﬁcations in terms of allowed speciﬁc absorbance ratio,
which was not exceeding 0.1 W/kg.
Data analysis
LFP and neuroimaging data were processed and analysed in
Matlab 7 (Mathworks, Sherborn, MA, USA). Image processing
was performed with the freely available Statistical Parametric
Mapping software (SPM8; Wellcome Trust Centre for
Neuroimaging, London, UK, http://www.ﬁl.ion.ucl.ac.uk/spm/
software/), running under Matlab 7. Probabilistic diffusion
tractography was performed with the FDT diffusion toolbox
in the framework of FSL (Behrens et al., 2007).
Analysis of local ﬁeld potential activity
The continuous LFP recordings of 180-s length were used for
the LFP analyses described in this section.
The power spectral density (PSD, in mV2/Hz) of the raw data
was computed with the standard fast Fourier transform (Welch
method, Hanning window of 1 s, 75% overlap) for each pa-
tient and medication condition separately. The power spectral
density (measured power: P) was then normalized into decibels
(dB) with the average power spectral density (reference power:
P0) within 105–195Hz (excluding the 145–155Hz range to
avoid possible harmonics of the 50Hz power line noise) to
account for between-subjects variability:




To conﬁrm that the OFF state was associated with a larger
beta-band (13–30Hz) LFP activity (Priori et al., 2004; Ku¨hn
et al., 2006), we ﬁrst tested for spectral power differences be-
tween the OFF and ON states within the 1–100Hz range. In
this analysis, we averaged for each patient the normalized
Table 1 Demographic and clinical information
Patient 1 2 3 4 5 6 7 8 9 10
Age 51 63 62 51 55 53 52 57 66 71
Gender M M M F M M M F F M
Disease duration (years) 6 11 8 14 8 10 15 13 12 11
Stimulating contacts (R L) 1 / 1 1 / 1 1 / 1 2-3 + / 2 3 / 3 3 / 3 1 / 1 3 / 3 3 / 3 1 / 1
Beta phase reversal OFF (R L) 2 / 2 (-) / 1 1 / (-) 1 / 2 1 / 2 (-) / 1 3 / 2 2 / (-) 2 / 2 3 / 1
UPDRS III preop. OFF 29 34 21 (n.a.) 34 42 50 36 24 30
UPDRS III preop. ON 3 14 12 (n.a.) 20 13 38 15 16.5 22
UPDRS III med OFF/ stim off 30 47 22 45 32 39 50 n.a. n.a. n.a.
UPDRS III med OFF/ stim on 8 12 14 8 16 14 28 n.a n.a n.a.
UPDRS III DBS improvement % 73.33 74.47 36.36 82.22 50.00 64.10 44.00 n.a n.a n.a
LEDD preop 402 1382 1580 675 1689 1552 875 1380 832 3395
LEDD reduction postop % 35.32 16.42 50.31 88.88 67.49 70 71.42 n.a. 18.02 77.94
Macroelectrode contacts are indicated as follows: R = Right, L = Left; contacts from most ventral to most dorsal 0-1-2-3; (-) indicates that a phase reversal could not be identiﬁed in
the recordings. UPDRS = Uniﬁed Parkinson’s Disease Rating Score, part III (range 0–108). M = males; F = females; n.a. = not available. LEDD = levodopa equivalent daily dose








power spectral density across all contact pairs (R01, R12,
R23, L01, L12, L23).
Next, to conﬁne the local generator of the beta-band activity
based on our bipolar LFP recordings, we used the analysis of
phase reversal of oscillatory activity (Rodriguez-Oroz et al.,
2011; Fig. 1), which provides a more consistent spatial local-
ization than the evaluation of the peak of activity in the spec-
tral power. The occurrence of signiﬁcant phase reversal
Figure 1 LFPs from STN-implanted macroelectrodes. (A) Representative time course of beta-band oscillatory activity in the right STN
obtained from bipolar recordings in Patient 1. Note the phase reversal (phr) occurring between R12 and R23 (phase reversal at contact R2). For
the power analysis, contact pair R12 was selected by convention (see main text) as the closest one to the source of beta activity (phase reversal).
(B) Histogram depicting the difference phase values between signals recorded from contact pairs R01 and R12 in Patient 1. The maximum of the
histogram is located at 0 radians (0), indicating no phase reversal between both pairs. (C) Same for the difference phase values between signals
recorded from contact pairs R12 and R23. In this case, the histogram attains its maximum value at  radians (180), indicating the occurrence of
phase reversal at contact R2. (D) Grand-average of the normalized spectral power OFF medication for the contact pair closest to the phase
reversal of beta-band activity (potential source; phase reversal, in black), and for the dorsal (d, orange line) and ventral (v, green line) contact pairs.
A signiﬁcant effect of localization on the spectral power was obtained within 26–30Hz (Kruskall-Wallis test, P5 Pth = 0.0208, after control of
FDR). The inset shows the mean value and corresponding standard error of the mean (SEM) for the spectral power (d, phr, v) averaged within the








between two pairs of bipolar recordings (i.e. between 12 and
23) indicates that the source of the activity, although spatially
distributed, lies closer to the contact shared by both bipolar
recordings (e.g. contact 2 in the previous example. As each
electrode has only four contacts, this analysis was limited to
three pairs per side; Fig. 1A–C).
Phase reversal was analysed for neighbouring contact pairs
in each STN, in the OFF condition. Prior to the phase reversal
analysis, the LFP signals were band-pass ﬁltered (ﬁnite impulse
response ﬁlter) between 13–30Hz to obtain the signal content
in the beta frequency range. Then, we applied the Hilbert
transform to extract the phase values ’i(t,f) for each band-
passed ﬁltered bipolar recording i, at time point t and within
the frequency band f. Our criterion of phase reversal was






exp i ’jk  ’ik
  
ð2Þ
where N is the signal length (N = 180 000 sampling points)
and
’ji;k ¼ ’jk  ’ik ð3Þ
is the phase difference between neighbouring signals i and j
from bipolar recordings at sampling (time) point k. A phase
reversal occurs when the resultant phase difference is within
the range (/2, 3/2) radians and is thus associated with a
negative cosine value (Fig. 1C). When a phase difference lies
within the range (/2,/2) radians, no phase reversal occurs
and, correspondingly, a positive cosine value is obtained
(Fig. 1B). The statistical evaluation of the phase reversal was
performed following Rodriguez-Oroz et al. (2011), with the
Rayleigh test of uniformity of angle by obtaining the signiﬁ-
cance value according to the expression:
exp Nv2  ð4Þ
where
v ¼ kVk ð5Þ
is the norm of the resultant vector v.
Following this procedure, we selected in each STN the con-
tact where the phase reversal occurred (e.g. 1) and, in addition,
the next one in the dorsal (e.g. 2) and ventral direction (e.g. 0)
along the macroelectrode axis (if available; note that whenever
the phase reversal was estimated to occur beyond contact 3,
there was no dorsal contact available; and whenever the phase
reversal was estimated to occur beyond contact 0, no ventral
contact was available. These estimations were based on a ten-
dency of the cosine towards more negative values, either in the
0 ! 1 ! 2 ! 3 direction or in the opposite direction.
However, these effects did not represent a true phase reversal).
Beta-band phase reversal occurred within the STN for the ma-
jority of the nuclei (n = 16/20). A detailed list of the contacts at
the phase reversal of beta LFP activity is provided in Table 1.
We then analysed the normalized spectral power with re-
spect to the localization of the contact pairs (in relation to
the beta-band phase reversal). The selection of contact pairs
for this analysis was based on the occurrence of a signiﬁcant
phase reversal: for phase reversal at contact 1 or 2 (left or
right STN), we selected contact pair 12 and 23, respectively,
as the closest one to the phase reversal. The remaining contact
pairs were deﬁned as ‘ventral’ to phase reversal contact pair
for the one caudal to the phase reversal contact pair, and
‘dorsal’ contact pair for the one rostral to the phase reversal
contact pair (if available, see above). Note that the contact
pairs choice in relation to phase reversal proximity (found
for only one contact) is arbitrary, but this criterion was kept
for consistency.
MRI data processing
The multi-parameter maps were only used for the purpose of
non-linear registration to standardized space.
Magnetization transfer maps were ﬁrst linearly registered to
the diffusion space (using as a destination volume the ﬁrst B0
diffusion acquisition) and then segmented according to the
standard uniﬁed segmentation approach in the framework of
SPM (Ashburner and Friston, 2005). Deformation ﬁelds from
the previous step allowed for the inverse deformation of
labelled probabilistic cortical atlases from Montreal
Neurological Institute (MNI) into individual native diffusion
space, as well as for the transformation of tractography results
into the common space for further analysis (see below). For
delineation and labelling of cortical areas we used a combin-
ation of freely available probabilistic atlases: the Juelich atlas
for medial temporal areas (Eickhoff et al., 2005, including
amygdala and hippocampus) and the Harvard-Oxford cortical
atlas (Desikan et al., 2006) for the remaining areas.
Each group of 10 diffusion-weighted images b = 1000 s/mm2
volumes was afﬁne registered to the respective reference b = 0
(b0) volume, and then with the ﬁrst b0 volume of the block
acquisition. Diffusion vector directions were corrected accord-
ingly with in-house Matlab code. Postoperative T2 images
were subsequently linearly co-registered with the average ref-
erence b0 volume, allowing for superposition of electrode arte-
facts on the diffusion native space. The accuracy of the
procedure was visually inspected, and coordinates of the cen-
tral voxel of contact artefact manually identiﬁed. From these
coordinates, cube-shaped seed masks for tractography were
built by expanding to all neighbouring voxels (total seed
volume = 27 voxels). We used the recently implemented
LEAD-DBS toolbox (Horn and Ku¨hn, 2015) to estimate con-
tacts coordinates in the MNI space, and their spatial localiza-
tion with respect to the STN Morel atlas (Krauth et al., 2010).
With the settings used, the toolbox allowed for subject-speciﬁc
non-linear registration after segmentation of structural images
(Supplementary Fig. 1).
Whole-brain unconstrained probabilistic tractography was
performed in subject speciﬁc native space using the default
settings in FSL bedpostx with the following parameters:
10 000 originating tracts per voxel, curvature 0.2, step length
0.5. Distributions of diffusion parameters were estimated at
each voxel to model the directions of up to two tensors per
voxel (Behrens et al., 2007). Through the option ‘classiﬁcation
targets’ we computed for each contact-surrounding seed the
average number of tracts reaching each cortical target.
To maintain consistency across subjects, tractography was
conducted seeding from contacts closest to the beta source
(hereafter contacts ‘B’), from the adjacent dorsal contact (con-
tacts ‘D’) and the adjacent ventral contact (contacts ‘V’). In the
case of contact ‘B’ being assigned to the most dorsal contact
(due to a trend towards a phase reversal beyond contact 3: 2/








excluded from analysis (contact ‘D’). The STNs showing no
phase reversal were excluded from this analysis (4/20 cases).
To reduce well-known biases affecting the probabilistic trac-
tography method (Morris et al., 2008), we excluded targets in
close proximity to the implanted electrodes, i.e. the basal gang-
lia. Moreover, the cingulate cortex was also excluded, after
demonstration of an important proximity bias: connectivity
values were strongly affected by the vicinity of corpus callosum,
so that it was not possible to reliably distinguish tracts directed
to cingulate cortex from inter-hemispherical projections.
For each side, seed-to-target connectivity matrices were
thresholded at 50 tracts, and the values were transformed
using the natural logarithm. Values were normalized in each
subject by dividing them by the maximum connectivity value.
Cortical targets were considered for further analysis only if
connected to at least 50% of contacts B or D or V.
Statistical analysis
Spectral power differences between the OFF and ON states
within the 1–100Hz range were tested by means of a non-
parametric pair-wise permutation test (Good, 2005) across n
subjects, with a total of 5000 random permutations. The dif-
ference in sample means was the test statistic. The P-values
were computed as the frequencies that the replications of the
test statistic had absolute values greater than or equal to the
experimental difference. Statistical tests of the changes in spec-
tral power were assessed at each frequency within 1–100 Hz.
The statistical assessment of a general effect of localization
(ventral, beta-band phase reversal, dorsal) on the spectral
power was performed by means of the non-parametric
Kruskal–Wallis one-way ANOVA test. This test was assessed
at each frequency bin between 13 and 30 Hz, to determine
whether the effect of pair localization on the beta-band spec-
tral power occurred in a speciﬁc sub-band or in the full beta
band.
Differences in connectivity among contacts B, D and V were
ﬁrst tested with the non- parametric Kruskal–Wallis test.
Post hoc analyses between D and B or between V and B con-
tacts were performed by means of pairwise permutation tests.
In all statistical analyses, differences were considered signiﬁ-
cant if P5 0.05. Correction of the signiﬁcance level due to
multiple comparisons was performed by controlling the false
discovery rate at level q = 0.05 by means of an adaptive two-
stage linear step-up procedure (Benjamini and Yekutieli, 2001).
The corrected threshold P-value obtained from this procedure,
Pth, was used to reject all null hypotheses fulﬁlling the condi-
tion: P-value5Pth. Throughout the paper, Pth is given when




All patients showed a good clinical response both to levo-
dopa [mean improvement in Uniﬁed Parkinson’s Disease
Rating Scale (UPDRS) III score = 52  7%, available for
9/10 patients] and to DBS (mean improvement with DBS
off versus on, medication OFF, available for 7/10
patients = 61  5%). Demographical and clinical informa-
tion is summarized in Table 1. Two patients presented with
mood disturbances after surgery (Patients 5 and 6). Patient
5 (male, 55 years old) developed hypomanic behaviour
with uncontrolled money spending and high irritability
(see below) 4 months after surgery. Patient 6 (male, 53
years old) also presented with transient hypomanic behav-
iour immediately after surgery. However, a retrospective
diagnosis of a pre-existing bipolar disorder could be estab-
lished based on new anamnestic information. Symptoms
stabilized under withdrawal of selective serotonin reuptake
inhibitors and treatment with valproic acid over a period of
a few weeks, and no clear relation with STN stimulation
could be identiﬁed.
Source localization of beta-band
local ﬁeld potential oscillations
and spectral power analysis
The average normalized spectral power OFF medication, as
compared to ON medication, exhibited signiﬁcantly larger
values in the lower beta range (13–20Hz, P5Pth = 0.031,
Supplementary Fig. 2). This outcome conﬁrmed that there
was a higher level of beta-band activity OFF medication,
which was assessed further using the phase reversal ana-
lysis. We found a signiﬁcant phase reversal of the beta-
band STN oscillatory activity OFF medication for the ma-
jority of the patients, and typically in both STNs (16 nuclei
of 20 in 10 patients, P5106, see Fig. 1A–C, and
Table 1). In four STNs stemming from four different pa-
tients, no signiﬁcant phase reversal could be found. For two
of these nuclei, postoperative imaging showed a slight
medial positioning of the macroelectrode (Patients 3 and
6). For all other patients postoperative imaging conﬁrmed
the optimal electrode placement with at least one contact of
the macroelectrode within STN.
The contacts closer to the beta source (contacts B), after
transformation of coordinates onto the standard MNI
space, were localized in the dorso-lateral (sensorimotor)
STN (average MNI coordinates in mm  SEM: right:
x = 11.25  0.41; y =12.62  0.90; z =6.62  0.41; left:
x =11.00  0.59; y = 13.12  0.51; z = 6.87  0.61;
Fig. 2). Neighbouring contacts located above (dorsal, contacts
D) the contact exhibiting the beta-band phase reversal were
placed mainly outside the STN, while contacts below (ventral,
contacts V) were still within the nucleus borders (Fig. 2).
The assessment of a general effect of contact pair local-
ization (beta-band phase reversal, dorsal and ventral) on
the normalized spectral power OFF medication, revealed
a signiﬁcant effect in the upper beta band within 26–
30Hz (Kruskal–Wallis test, P5Pth = 0.0208; Fig. 1D).
This was due to consistently larger beta-band power
values at the phase reversal contact pairs, relative to the
ventral and dorsal contact pairs. Accordingly, the analysis
of the normalized spectral power based on the phase rever-








speciﬁc effect. By contrast, power analysis in the case of
classiﬁcation of contact pairs based on the peak of beta-
band oscillatory activity revealed largely non-frequency spe-
ciﬁc (and non-signiﬁcant) power modulations
(Supplementary Fig. 3).
Deep brain stimulation contacts:
anatomical connectivity
Probabilistic tractography seeding from contacts B revealed
a high connectivity to motor and premotor areas, and to a
lesser extent to medial temporal and post-central structures
(descriptive results in Fig. 3). In contrast, connectivity to
amygdala, hippocampus and post-central gyrus were max-
imal from contacts V, and progressively reducing in the
dorsal direction (Fig. 3). Connectivity to superior, middle
and inferior frontal gyri, and supplementary motor cortex
were highest in contacts D, intermediate in contacts B, and
lowest in contacts V (Fig. 3).
The cortical areas that fulﬁlled both our criteria of
(i) 450 tract thresholding; and (ii) greater connectivity to
at least 50% of either contacts B, D, and V included the
frontal pole, superior, middle and inferior frontal gyrus,
precentral gyrus, supplementary motor cortex, amygdala,
hippocampus, superior parietal lobule, precuneus, and lat-
eral occipital cortex. The non-parametric Kruskal–Wallis
test revealed a main effect of contact localization (three
levels: D, B, V) on the normalized connectivity to the amyg-
dala, hippocampus, superior, middle and inferior frontal
gyri, post-cental gyrus, supplementary motor cortex
[P5Pth = 0.01, after control of false discovery rate (FDR)
at level q = 0.05; Figs 3 and 4]. Post hoc analysis by means
of permutation tests showed that contacts B had a signiﬁ-
cantly higher connectivity to the amygdala and smaller con-
nectivity to the superior frontal gyrus than contacts D
(P5Pth = 0.01). Compared to contacts V, contacts B had
signiﬁcantly smaller connectivity to the amygdala, whereas
they had larger connectivity to the supplementary motor
cortex, and the superior, middle and inferior frontal gyri
(P5Pth = 0.016). Hence, in a dorso-ventral direction we
described an increasing connectivity gradient to the amyg-
dala, and a decreasing gradient of connectivity to supple-
mentary motor cortex and the superior, middle and inferior
frontal gyri.
Figure 2 Localization of contacts in relation to the STN. Contacts coordinates were non-linearly registered to the MNI standard space,
and superimposed to a STN 3D representation of the Morel stereotactic atlas (Krauth et al., 2010). (A) 3D rendering of all leads postoperative
position from a dorsal (left) and posterior (right) view. (B) Distribution model (coordinates average and covariance) of contacts in relation to the
source of the beta oscillation. Contacts most close (contacts B, middle) lie in the dorso-lateral STN while neighbouring dorsal contacts (contacts








Figure 3 Probabilistic diffusion tractography from STNmacroelectrode contacts. Top row: Connectivity proﬁle of contacts closest to
source of beta oscillations (contacts B). Regions with highest connectivity (yellow) include precentral gyrus and superior frontal gyrus. Lower
connectivity values were found for prefrontal cortex and medial temporal regions. Middle row: Normalized difference of connectivity values:
contacts dorsal to beta minus contacts closest to beta source [D()B]. Bottom row: Contacts ventral to beta minus contacts closest to beta source
[V()B]. More dorsal contacts show higher connectivity to prefrontal associative regions, while most ventral contacts have higher connectivity to
medial temporal and orbitofrontal regions.
Figure 4 Kruskal–Wallis test showing a signiﬁcant (asterisk) effect of localization for connectivity to cortical targets surviving
threshold. For further details see ‘Patients and methods’ section. Columns represent normalized difference of connectivity values between (i)
contacts dorsal to beta (D, orange) and contacts closest to beta source: D  source; and (ii) contacts ventral (V, green) to beta and contacts
closest to beta source: V  source. Connectivity to amygdala and hippocampus increases towards more ventral contacts, whereas more dorsal
contacts show increased connectivity to prefrontal cortex (superior, middle and inferior frontal gyrus) and supplementary motor cortex (SMC),
and decreased connectivity to postcentral gyrus. Signiﬁcance is set at P5 Pth = 0.01, after control of false discovery rate at level q = 0.05. On the








Index case: clinical and imaging
ﬁndings
Patient 5 (male, 54 years old at surgery) developed stimu-
lation-induced hypomanic episodes. The patient underwent
STN stimulation with no peri-operative complications and
good motor response after activation of contacts 1R and
1L (second contact proceeding ventro-dorsally, right and
left, respectively). For the same contacts, we observed the
appearance of hemi-corporal sensory symptoms at 2.4V
amplitude bilaterally. Over the next few months, the posi-
tive effect on the motor symptoms waned progressively,
prompting successive adaptations including shifting to the
contacts above (2R and 2L). The pharmacological treat-
ment was also optimized and included levodopa/carbi-
dopa/entacapone and pramipexole. The total amount was
40% less than before surgery.
Six days after the last stimulation voltage increase to
2.5V (right STN) and 2.7V (left STN), 60 ms, 130Hz,
the patient complained of restlessness and irritability. His
son reported irascible behaviour and episodes of uncon-
trolled, unnecessary money spending (mounting up to a
car purchase). The psychiatric symptoms were almost com-
pletely resolved by reducing the intensity of the stimulation
to 2.0V and 2.1V while the patient did not tolerate further
reduction of the oral treatment. The lasting emotional irrit-
ability during in-patient care evolved further in a hypo-
manic state. The restlessness and logorrhoea could be
prompted by increasing the stimulation voltage at contacts
2 bilaterally to rapidly disappear when the DBS was turned
off. The psychiatric assessment was consistent with DBS-
induced manic episodes given that the patient had no simi-
lar symptoms prior to surgery. After stimulation was
shifted to most dorsal contacts (3R and 3L), there was a
prompt optimal motor response associated with a subject-
ive appeasing sensation. In the long-term observation there
was a complete resolution of the psychiatric symptoms des-
pite further increases in voltage up to 2.9V in the right and
2.7V in left STN.
The stereotactic localization according to the Morel STN
atlas showed that the contacts eliciting hypomanic mani-
festations were positioned slightly anterior and ventral
to the putative motor area, particularly in the left STN
(Fig. 5A). The connectivity results in this patient conﬁrmed
the trend observed in the rest of the population (Fig. 5B).
The tracts originating from the contacts 2 bilaterally were
subtracted from those originating from contacts 3. Ventral
contacts, eliciting manic manifestations (contacts 2R and
2L) had higher connectivity to medial temporal cortex,
and lower to primary motor cortex as compared to
dorsal contacts (contacts 3R and 3L). There was a certain
asymmetry, with the left STN showing globally lower con-
nectivity to prefrontal cortex. Clinical testing was not con-
ducted separately for each side, so it was not possible to
ascertain whether psychiatric side effects were caused pre-
dominantly by one of the two macroelectrodes.
Discussion
In our study we combine neurophysiological recordings
with MRI to investigate in vivo subthalamic nucleus’ func-
tional organization. In the effort of overcoming the limita-
tions of both methods, we gather evidence on the existence
of overlapping functional subregions within the nucleus.
Our results provide a neurobiological interpretation of the
manifold clinical effects of DBS to further yield valuable
information guiding clinical decision-making. These ﬁnd-
ings expand the current knowledge suggesting a rather
complex and possibly subject-speciﬁc interplay between
anatomical connectivity and neural activity patterns.
Sensory-motor subthalamic nucleus
We found that the target for DBS—the dorso-lateral STN—is
characterized by beta oscillations and anatomical connections
to motor cortical areas, suggesting a link between electro-
physiological activity, connectivity, and function. Our neuro-
physiological ﬁndings conﬁrm previous reports based on
single unit recordings and LFP spectral analysis (Ku¨hn
et al., 2005; Weinberger et al., 2006; Trottenberg et al.,
2007; Zaidel et al., 2010). The depicted anatomical network
of the STN beta oscillatory region is compatible with the
sensorimotor function previously attributed to the beta
rhythm (Engel and Fries, 2010; Little and Brown, 2014).
The most highly connected targets include sensorimotor
areas—precentral, postcentral gyrus, supplementary motor
cortex. This ﬁnding is consistent with the ‘hyper-direct’ path-
way connecting primary motor areas with the dorso-lateral
STN (Nambu et al., 1996; Whitmer et al., 2012; Haynes and
Haber, 2013), and with the beta-coherence observed between
STN and M1 (Marsden et al., 2001; Fogelson et al., 2006;
Litvak et al., 2011).
The current knowledge about the generator of beta oscil-
lations recorded from the STN is sparse; however, strong
evidence indicates that cortical activity drives beta oscilla-
tions in the STN (Fogelson et al., 2006; Lalo et al., 2008;
Litvak et al., 2011; Hirschmann et al., 2013). Although not
statistically signiﬁcant, we found that contacts closest to the
beta source had highest connectivity to the precentral
gyrus. This could represent the anatomical basis of the
observed beta coherence among STN and precentral gyrus
activity as recorded from subdural electrodes (Whitmer
et al., 2012).
Besides conﬁrming the known topography of the sensori-
motor STN, we restrain from oversimplifying STNs func-
tional organization. The demonstrated pattern of
connectivity strongly suggests that STN areas involved in
the origin of beta activity in Parkinson’s disease project not
only to sensorimotor areas, but also to regions involved in
cognitive and emotional/behavioural functions: contacts B
were also highly connected to prefrontal regions, including
superior, middle and inferior frontal gyri; higher order sen-
sory areas in the post-central gyrus, precuneus, superior








regions also showed high connectivity with ‘beta’ contacts.
These results have to be interpreted with caution given
major limitations in spatial resolution of MRI that we
tried to overcome. However, we estimate that our careful
beta source localization, high resolution DWI sequence
(1.7 mm isotropic), and probabilistic tractography reached
a sufﬁcient reliability for inferring STN’s functional organ-
ization. The notion of a tripartite STN—constituted by
motor, associative and limbic functional subregions—is sup-
ported by consistent evidence (Krack et al., 2001; Hamani
et al., 2004; Mallet et al., 2007; Karachi et al., 2009;
York et al., 2009). However, STN anatomo-functional
subdivisions are not clear-cut as demonstrated by anatomical
and neurophysiological evidence. Distribution of prefrontal
projections to STN in the non-human primate (Haynes and
Haber, 2013) and in humans as captured by recent imaging
studies (Mallet et al., 2007; Brunenberg et al., 2012;
Lambert et al., 2012; Accolla et al., 2014) show convergence
and multiple areas of overlap. STN subareas are also not
clearly segregated from a neurophysiological point of view,
as ﬁring pattern modiﬁcations secondary to sensory-motor
tasks have been observed in regions with no prominent beta
activity (Zaidel et al., 2010). Given these premises, our data
further support that (i) beta oscillations are not restricted to
Figure 5 Imaging data of Patient 5. This subject had a signiﬁcant motor improvement after stimulation from contacts 2 (right and left), but
developed manic behaviour and restlessness. After shifting more dorsally (contacts 3 bilaterally) motor beneﬁt was maintained, and psychiatric
manifestations relieved. (A) MNI localization of stimulating contacts, superimposed to the Morel STN atlas (in purple, from Krauth et al., 2010).
Top row: axial view, with z coordinates specifying the section level (vertical axis). Bottom row: sagittal view, with x coordinates (right to left axis).
Contacts eliciting hypomanic manifestations (2L and 2R) are located in a more anterior and ventral position within the nucleus. (B) Voxelwise,
whole brain connectivity difference between contacts 2 and 3 (both sides computed separately) are shown (coronal view). In blue/light-blue voxels
with higher connectivity to ventral contacts (contacts 2 versus contacts 3). In orange/red voxels with higher connectivity to dorsal contacts
(contacts 3). Values represent the difference of number of tracts passing from each voxel. (C) Transversal sections at different z coordinates.
Ventral contacts have higher connectivity to medial temporal structures, including amygdala, while more dorsal contacts have higher connectivity








a ‘motor’ STN area; and (ii) that the ‘motor’ STN is not
connected exclusively with motor cortical areas. We here
show that where the electrophysiological source of beta ac-
tivity is found, motor connectivity is predominant, but not
exclusive. We conclude that beta oscillations have a main
but not exclusive motor signiﬁcance, and that STN might be
organized following a topographical specialization by which
predominant function at each location is constantly in-
formed by other circuits’ activity.
Subthalamic nucleus connectivity to
limbic cortical areas
Comparison of neighbouring contacts revealed a signiﬁ-
cantly higher connectivity of ventral STN to limbic
targets—medial temporal structures including hippocampus
and amygdala. This principle of organization was also
observed at the single subject level in a patient with DBS
induced hypomanic manifestations. The involvement of
amygdala and hippocampus in manic states—mostly inves-
tigated in the context of bipolar disorder—is well docu-
mented, with reported volume differences among patients
and healthy subjects (Schneider et al., 2012), and increased
blood oxygen level-dependant functional MRI signal in re-
sponse to affective faces during mania (Altshuler et al.,
2005; Malhi et al., 2007; Strakowski et al., 2012). In
light of our ﬁndings, we provide a new interpretation of
the previous report about STN-DBS induced decrease in
regional cerebral blood ﬂow, observed in the left medial
and inferior temporal cortex in patients developing hypo-
maniac behaviour after stimulation (Ulla et al., 2011). The
presumption here is that STN-DBS induces hypomanic
manifestations by modulating STNs impact on medial tem-
poral lobe structures through inhibition of predominantly
excitatory projections. Along these lines, in our index case
we could not conﬁrm the supposition that direct stimula-
tion of substantia nigra structures is eliciting hypomanic
symptoms (Ulla et al., 2011) or acute depressive state
(Bejjani et al., 1999) as described previously. Altogether,
our ﬁndings provide a plausible anatomical substrate for
the occurrence of (hypo)manic states following STN DBS,
and a rationale for improvement observed when shifting
stimulation dorsally.
Methodological considerations
Our approach to differentiate STN contact pairs based on
the proximity to the beta-band phase reversal aimed at
increasing spatial resolution, and strengthens the validity
of our conclusions. The alternative approach, based solely
on maximum spectral power, was not frequency-speciﬁc
(Supplementary Fig. 3). Rather, this approach revealed
that the contact pair with maximum power in the beta
range also exhibited maximum power in neighbouring fre-
quency ranges, therefore suggesting a generally larger
signal-to-noise ratio in these contacts but not a speciﬁc
contact localization in the proximity of the generator of
beta oscillations. With this respect, the phase reversal ana-
lysis provides a higher accuracy for spatial localization of
oscillatory activity in a speciﬁc frequency range (Rodriguez-
Oroz et al., 2011).
One limitation of the beta source localization lies in the
few available contact pairs per STN: four contacts amount-
ing to three contact pairs. A larger number of contact pairs
per STN could lead to a more accurate spatial localization
of the beta oscillations, although it should also be noted
that the beta-band activity pattern is not expected to be
localized to a single focal point within the STN but may
rather be spatially distributed across the dorso-lateral STN.
An additional limitation that affects exclusively the power
analysis is that it was necessary to set a criterion upon
which to select the contact ‘pair’ closest to the phase rever-
sal. That is, if a phase reversal was found between contact
pairs 01 and 12, there was no ambiguity with regard to
which ‘contact’ was closest to the phase reversal (here con-
tact 1), but it was indeed necessary to decide which contact
pair from the two containing the phase-reversal contact (1)
should be selected for power analysis. Importantly, how-
ever, the connectivity analysis was not affected by this
ambiguity.
In conclusion, our study expands the knowledge of STN
anatomy and describes anatomical networks potentially
modulated by DBS. We failed to address more speciﬁc clin-
ical questions due to the retrospective nature of clinical
data. We nevertheless here demonstrate the advantages of
merging clinical, neurophysiological and neuroimaging data
in investigating speciﬁc neuro-scientiﬁc questions relevant
for medical purposes. We propose that future strategies
for improving DBS outcome should focus beyond the sche-
matic tripartite principle of organization, to target individu-
ally the optimal STN stimulation site.
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